Association Between Medication Adherence and Glycemic Control of Prolanis Participants With Type 2 Diabetes Mellitus Patients at Prambanan Public Health Center

Authors

  • Amaliyah Nur Khasanah Fakultas Kedokteran dan Ilmu-Ilmu Kesehatan, Universitas Alma Ata, Jalan Brawijaya Nomor 99, Yogyakarta, 55183, Daerah Istimewa Yogyakarta, Indonesia, Indonesia
  • RA Dewinta Sukma Ananda Fakultas Kedokteran dan Ilmu-Ilmu Kesehatan, Universitas Alma Ata, Jalan Brawijaya Nomor 99, Yogyakarta, 55183, Daerah Istimewa Yogyakarta, Indonesia, Indonesia
  • Eva Nurinda Fakultas Kedokteran dan Ilmu-Ilmu Kesehatan, Universitas Alma Ata, Jalan Brawijaya Nomor 99, Yogyakarta, 55183, Daerah Istimewa Yogyakarta, Indonesia, Indonesia
  • Ari Susiana Wulandari Fakultas Kedokteran dan Ilmu-Ilmu Kesehatan, Universitas Alma Ata, Jalan Brawijaya Nomor 99, Yogyakarta, 55183, Daerah Istimewa Yogyakarta, Indonesia, Indonesia

DOI:

https://doi.org/10.70410/jfg.v13i2.427

Keywords:

diabetes mellitus, adherence, glycemic control, public health center

Abstract

Diabetes Mellitus (DM) is one of the four non-communicable diseases categorized as a top priority, requiring long-term management to prevent serious complications. Glycemic control is a critical factor in managing the disease, yet medication non-adherence remains a significant challenge. The Chronic Disease Management Program (Prolanis) aims to optimize participants' quality of life via BPJS Kesehatan (National Health Insurance provider). This study aimed to determine the relationship between therapeutic adherence and glycemic control among Type 2 Diabetes Mellitus (T2DM) Prolanis participants at the Prambanan Public Health Center, Sleman. This observational study employed a cross-sectional design and included 34 participants who met the inclusion and exclusion criteria. The results indicated that the majority of participants—21 individuals (61.8%)—were non-adherent to therapy, with 12 of them (57.1%) having uncontrolled glycemic levels. Among the 13 participants (38.2%) who adhered to therapy, 11 (84.6%) achieved controlled glycemic levels. There was an association between therapeutic adherence and glycemic control in T2DM Prolanis participants at the Prambanan Public Health Center, Sleman.

Downloads

Download data is not yet available.

References

American Diabetes Association Professional Practice Committee. (2023). 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024. Diabetes Care, 47(Supplement_1), S111–S125. https://doi.org/10.2337/dc24-S006

Ananda, R. D. S., Pratiwi, W. R., & Kristin, E. (2019). Adherence and Glycemic Control Among Type 2 Diabetes Mellitus Patients Using Antidiabetic Medication: A Cross Sectional Study on Population Registered in Sleman Health and Demographic Surveillance System. J. Pharm. Sci., 11. Available at : https://www.proquest.com/openview/e125332770c654d8aaef48a77e95a1e4/1?pq-origsite=gscholar&cbl=54977

Apristina, A., Nurinda, E., Kusumawardani, N., Yugistyowati, A., & Dwinta, E. (2023). Analisis Hubungan Tingkat Kepatuhan Penggunaan Obat terhadap Luaran Klinis Pasien PROLANIS Program Rujuk Balik Diabetes dengan Hipertensi di Puskesmas Minggir pada Masa Pandemi COVID-19: Tingkat Kepatuhan Penggunaan Obat terhadap Luaran Klinis Pasien PROLANIS Diabetes dengan Hipertensi di Masa Pandemi COVID-19. Pharmaceutical Journal of Indonesia, 8(2). https://doi.org/10.21776/ub.pji.2023.008.02.6

Arfania, M., Hidayat, S. Z. P. H. Z. P., & Amal, S. (2022). FAKTOR YANG MEMPENGARUHI KEPATUHAN PENGOBATAN DIABETES MELITUS TIPE 2 DI RUMAH SAKIT SWASTA KARAWANG. Journal of Pharmacopolium, 5(3). https://doi.org/10.36465/jop.v5i3.913

Badan Penelitian dan Pengembangan Kesehatan, -. (2020). Laporan Nasional Riskesdas 2018. https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/

Bonger, Z., Shiferaw, S., & Tariku, E. Z. (2018). Adherence to diabetic self-care practices and its associated factors among patients with type 2 diabetes in Addis Ababa, Ethiopia. Patient Preference and Adherence, 12, 963–970. https://doi.org/10.2147/PPA.S156043

Elm, E. von, Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, for the S. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PLOS Medicine, 4(10), e296. https://doi.org/10.1371/journal.pmed.0040296

Fandinata, S. S., & Darmawan, R. (2020). Pengaruh Kepatuhan Minum Obat Oral Anti Diabetik Terhadap Kadar Gula Darah Pada Pasien Diabetes Mellitus Tipe II. Jurnal Bidang Ilmu Kesehatan, 10(1), 23–31. https://doi.org/10.52643/jbik.v10i1.825

Ginting, S., Tampubolon, E. M., & Batubara, S. (2020). FAKTOR FAKTOR YANG MEMENGARUHI KEIKUTSERTAAN PESERTA BPJS MELAKUKAN SENAM PROLANIS DI PUSKESMAS MARTIMBANG KOTA PEMATANGSIANTAR TAHUN 2017. Jurnal Inovasi Kesehatan Masyarakat, 1(2), 46–51. https://doi.org/10.36656/jikm.v1i2.265

Husna, A. H., Jafar, N., Hidayanty, H., M.Dachlan, D., & Salam, A. (2022). HUBUNGAN KEPATUHAN MINUM OBAT DENGAN GULA DARAH PASIEN DM TIPE II DI PUSKESMAS TAMALANREA MAKASSAR: HUBUNGAN KEPATUHAN MINUM OBAT DENGAN GULA DARAH PASIEN DM TIPE II DI PUSKESMAS TAMALANREA MAKASSAR. Jurnal Gizi Masyarakat Indonesia (The Journal of Indonesian Community Nutrition), 11(1). https://doi.org/10.30597/jgmi.v11i1.20702

Kardela, W., Agustina, E., Harartasyahrani, R. A., & Bellatasie, R. (2023). Korelasi Tingkat Kepatuhan Pengobatan terhadap Kadar Glukosa Darah pada Pasien Geriatri Diabetes Melitus Tipe 2 di Puskesmas Kota Padang: Correlation of Medication Adherence to Blood Glucose Levels among Geriatric Patients with Type 2 DM at Health Center in Padang. JOPS (Journal of Pharmacy and Science), 6(2), 184–197. https://doi.org/10.36341/jops.v6i2.3504

Kementrian Kesehatan RI. (2013). Laporan Riskesdas Tahun 2013. Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan RI.

Ningrum, V. D. A., Ikawati, Z., Sadewa, A. H., & Ikhsan, M. R. (2017). Kontrol Glikemik dan Prevalensi Gagal Ginjal Kronik pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Wilayah Provinsi DIY Tahun 2015. Indonesian Journal of Clinical Pharmacy, 6(2), 78–90. https://doi.org/10.15416/ijcp.2017.6.2.78

Noviyantini, N. P. A., Wicaksana, A. L., & Pangastuti, H. S. (2020). Kualitas Hidup Peserta Prolanis Diabetes Tipe 2 di Yogyakarta. Jurnal Persatuan Perawat Nasional Indonesia (JPPNI), 4(2), 98–107. https://doi.org/10.32419/jppni.v4i2.183

Polonsky, W. H., & Henry, R. R. (2016). Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient Preference and Adherence, 10, 1299–1307. https://doi.org/10.2147/PPA.S106821

Putri, E. D. M., Ananda, R. D. S., Nurinda, E., & Wulandari, A. S. (2024). HUBUNGAN ANTARA KONTROL GLIKEMIK DENGAN TINGKAT KUALITAS HIDUP PESERTA PROLANIS PENDERITA DIABETES MELITUS TIPE 2 DI PUSKESMAS PRAMBANAN SLEMAN. Jurnal Insan Farmasi Indonesia, 7(3), 259–268. https://doi.org/10.36387/jifi.v7i3.2167

Ratnasari, P. M. D., Ardeliani, I. G. A. I., & Yuliawati, A. N. (2021). ANALISIS HUBUNGAN KEPATUHAN PENGOBATAN TERHADAP KONTROL GLIKEMIK PASIEN DIABETES MELITUS TIPE 2 DI INSTALASI RAWAT JALAN RUMAH SAKIT “X†BULELENG. JIIS (Jurnal Ilmiah Ibnu Sina): Ilmu Farmasi dan Kesehatan, 6(2), 331–340. https://doi.org/10.36387/jiis.v6i2.739

Rusminingsih, E., & Purnomo, R. T. (2022). Relationship of Patient Characteristics with Medication Adherence in Type 2 DM. Indonesian Journal of Global Health Research, 4(3), 603–610. https://doi.org/10.37287/ijghr.v4i3.1316

Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., Williams, R., & IDF Diabetes Atlas Committee. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843

Silalahi, L. (2019). Hubungan Pengetahuan dan Tindakan Pencegahan Diabetes Mellitus Tipe 2. Jurnal Promkes: The Indonesian Journal of Health Promotion and Health Education, 7(2), 223–232. https://doi.org/10.20473/jpk.V7.I2.2019.223-232

Umsipyat, A. S., Ananda, R. A. D. S., Nurinda, E., & Wulandari, A. S. (2025). The Perbandingan Kualitas Hidup Peserta Prolanis Diabetes Melitus Tipe 2 yang Memperoleh Monoterapi dan Politerapi di Puskesmas Prambanan Sleman. Journal of Pharmaceutical and Sciences, 1732–1739. https://doi.org/10.36490/journal-jps.com.v8i3.588

Vandenbroucke, J. P., Elm, E. von, Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, for the S. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. PLOS Medicine, 4(10), e297. https://doi.org/10.1371/journal.pmed.0040297

Wahyudi, Andrey., & Arifah, N. (2019). Asosiasi Kepatuhan Terhadap Luaran Terapi Pada Pasien Diabetes Mellitus Tipe II Di RSUD Wirosaban Kota Yogyakarta. Indonesian Journal of Pharmacy and Natural Product, 02, 4–7. https://doi.org/https://doi.org/10.35473/ijpnp.v5i1.1567

Wicaksana, A., & Rachman, T. (2023). Profil Kesehatan D.I.Yogyakarta Tahun 2022. Angewandte Chemie International Edition, 6(11), 951–952., 3(1), 10–27. Available at : https://kesehatan.jogjakota.go.id/uploads/dokumen/profil_dinkes_2022_data_2021_fix.pdf

Downloads

Published

2026-08-31

How to Cite

Khasanah, A. N., Ananda, R. D. S., Nurinda, E., & Wulandari, A. S. (2026). Association Between Medication Adherence and Glycemic Control of Prolanis Participants With Type 2 Diabetes Mellitus Patients at Prambanan Public Health Center. Jurnal Farmasi Galenika, 13(2), 141–151. https://doi.org/10.70410/jfg.v13i2.427

Citation Check